Companies › Provesica

Provesica

Healthcare 📍 Cambridge, United Kingdom 👥 1-10 employees 💰 $6.2M raised 📅 Founded 2010

Provesica is a Cambridge-based biopharmaceutical company specialising in overactive bladder. The Company’s development compound, XEN-D0501, is highly potent antagonist of the vanilloid receptor, TRPV1, and is about to start Phase 2 clinical development. In addition to XEN-D0501, Provesica owns a portfolio of intelle

📊 Company Overview

Sector
Healthcare
Country
United Kingdom
Employees
1-10
Total Raised · Venture
$6.2M
Founded
2010
Cloud
Unknown

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider
Workspace🔒 Subscribers only
CDN🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$18K $45K / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms🔒 Subscribers only
Analytics & CRM🔒 Subscribers only
CMS / Platform🔒 Subscribers only
Frontend Stack🔒 Subscribers only

Detected from Provesica's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

Data detected 2026-06-13 · Methodology · Suggest a correction